drospirenone has been researched along with Activated Protein C Resistance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Douxfils, J; Duijkers, I; Foidart, JM; Jost, M; Kinet, V; Klipping, C; Maillard, C; Mawet, M; Rosing, J | 1 |
| Noort, I; Rosendaal, FR; Rosing, J; van Vliet, HA; Winkel, TA | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
1 trial(s) available for drospirenone and Activated Protein C Resistance
| Article | Year |
|---|---|
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Menstrual Cycle; Middle Aged; Sex Hormone-Binding Globulin; Young Adult | 2020 |
2 other study(ies) available for drospirenone and Activated Protein C Resistance
| Article | Year |
|---|---|
Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Humans; Male; Middle Aged; Predictive Value of Tests; Thrombophilia | 2004 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |